These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 16646861)

  • 21. Methods for deriving pesticide aquatic life criteria.
    TenBrook PL; Tjeerdema RS; Hann P; Karkoski J
    Rev Environ Contam Toxicol; 2009; 199():19-109. PubMed ID: 19110939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Boosted protease inhibitor-based or nonnucleoside reverse transcriptase-based HAART: is there a best choice for antiretroviral-naive HIV-1 infected patients?
    Cuzin L; Allavena C; Morlat P; Dellamonica P
    AIDS Rev; 2008; 10(4):205-11. PubMed ID: 19092976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypothesis testing in functional linear regression models with Neyman's truncation and wavelet thresholding for longitudinal data.
    Yang X; Nie K
    Stat Med; 2008 Mar; 27(6):845-63. PubMed ID: 17610294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experiments.
    Rème T; Hose D; De Vos J; Vassal A; Poulain PO; Pantesco V; Goldschmidt H; Klein B
    BMC Bioinformatics; 2008 Jan; 9():16. PubMed ID: 18190711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quick calculation for sample size while controlling false discovery rate with application to microarray analysis.
    Liu P; Hwang JT
    Bioinformatics; 2007 Mar; 23(6):739-46. PubMed ID: 17237060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of the QRS complex by linear prediction.
    Hadj Slimane ZE; Bereksi Reguig F
    J Med Eng Technol; 2006; 30(3):134-8. PubMed ID: 16772215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.
    Brumme ZL; Tao I; Szeto S; Brumme CJ; Carlson JM; Chan D; Kadie C; Frahm N; Brander C; Walker B; Heckerman D; Harrigan PR
    AIDS; 2008 Jul; 22(11):1277-86. PubMed ID: 18580606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple test procedures using an upper bound of the number of true hypotheses and their use for evaluating high-dimensional EEG data.
    Hemmelmann C; Ziegler A; Guiard V; Weiss S; Walther M; Vollandt R
    J Neurosci Methods; 2008 May; 170(1):158-64. PubMed ID: 18279970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mother to child transmission of HIV-1 in a Thai population: role of virus characteristics and maternal humoral immune response.
    Kittinunvorakoon C; Morris MK; Neeyapun K; Jetsawang B; Buehring GC; Hanson CV
    J Med Virol; 2009 May; 81(5):768-78. PubMed ID: 19319941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
    Liu J; Yue J; Wu S; Yan Y
    Arch Virol; 2007; 152(10):1799-805. PubMed ID: 17619115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virological characterization of patients treated early is able to control HIV-1 replication after multiple cycles of structured therapy interruption.
    Rozera G; Abbate I; D'Offizi G; Corpolongo A; Narciso P; Vlassi C; Martini F; Calcaterra S; Capobianchi MR
    J Med Virol; 2007 Aug; 79(8):1047-54. PubMed ID: 17597482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Power and sample size when multiple endpoints are considered.
    Senn S; Bretz F
    Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of phenotypic susceptibility to antiretroviral drugs using physiochemical properties of the primary enzymatic structure combined with artificial neural networks.
    Kjaer J; Høj L; Fox Z; Lundgren JD
    HIV Med; 2008 Oct; 9(8):642-52. PubMed ID: 18631257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.
    Martinez-Picado J; Martínez MA
    Virus Res; 2008 Jun; 134(1-2):104-23. PubMed ID: 18289713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insertions in the beta3-beta4 loop of reverse transcriptase of human immunodeficiency virus type 1 and their mechanism of action, influence on drug susceptibility and viral replication capacity.
    Eggink D; Huigen MC; Boucher CA; Götte M; Nijhuis M
    Antiviral Res; 2007 Aug; 75(2):93-103. PubMed ID: 17416429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Super learner.
    van der Laan MJ; Polley EC; Hubbard AE
    Stat Appl Genet Mol Biol; 2007; 6():Article25. PubMed ID: 17910531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved family-wise error rate control in multiple equivalence testing.
    Leday GGR; Hemerik J; Engel J; van der Voet H
    Food Chem Toxicol; 2023 Aug; 178():113928. PubMed ID: 37406754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimality of the Holm procedure among general step-down multiple testing procedures.
    Gordon AY; Salzman P
    Stat Probab Lett; 2008 Sep; 78(13):1878-1884. PubMed ID: 19759804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. False discovery rate paradigms for statistical analyses of microarray gene expression data.
    Cheng C; Pounds S
    Bioinformation; 2007 Apr; 1(10):436-46. PubMed ID: 17597936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Only slight impact of predicted replicative capacity for therapy response prediction.
    Weisser H; Altmann A; Sierra S; Incardona F; Struck D; Sönnerborg A; Kaiser R; Zazzi M; Tschochner M; Walter H; Lengauer T
    PLoS One; 2010 Feb; 5(2):e9044. PubMed ID: 20140263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.